UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | H | I | J | K | L | M | O | P | S | T | V | W | Y
Number of items: 59.

A

Ahluwalia, J; Tinker, A; Clapp, LH; Duchen, MR; Abramov, AY; Pope, S; Nobles, M; (2004) The large-conductance Ca2+-activated K+ channel is essential for innate immunity (Retracted article. See vol. 468, 2010). NATURE , 427 (6977) 853 - 858. 10.1038/nature02356.

B

Bell, RM; Cave, AC; Johar, S; Hearse, DJ; Shah, AM; Shattock, MJ; (2004) Pivotal role of gp91phox-containing NADPH oxidase in early ischemic preconditioning. In: (Proceedings) 18th World Congress of the International-Society-for-Heart-Research. (pp. pp. 178-179). ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD

Bose, AK; Mocanu, M; Mensah, K; Brand, CL; Carr, RD; Yellon, DM; (2004) GLP-1 protects ischemic and reperfused myocardium via PI3kinase and p42/p44 MAPK signalling pathways. In: DIABETES. (pp. A1 - A1). AMER DIABETES ASSOC

Bose, AK; Mocanu, MM; Brand, CL; Carr, RD; Yellon, DM; (2004) Glucagon like peptide-1 (GLP-1) provides protection against cardiac ischaemia/reperfusion injury in both in vivo and in vitro experimental model in the rat. In: HEART. (pp. A23 - A23). B M J PUBLISHING GROUP

Bose, AK; Mocanu, MM; Carr, RD; Brand, CL; Yellon, DM; (2004) Myocardial infarct size attenuation by glucagon like peptide-1 (GLP-1) in both in vivo and in vitro rat heart. In: DIABETOLOGIA. (pp. A46 - A46). SPRINGER

Bose, AK; Mocanu, MM; Carr, RD; Yellon, DM; (2004) Glucagon-like peptide-1 mediated cardiac protection against ischemia/reperfusion injury involves multiple pro survival pathways. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 288 - 289). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Bose, AK; Mocanu, MM; Inst, H; Brand, CL; Carr, RD; Yellon, DM; (2004) Glucagon-like peptide-1 (GLP-1), a gut incretin, protects the myocardium against ischemic/reperfusion injury through the myocardial GLP-1 receptor and activation of prosurvival pathways. In: CIRCULATION. (pp. 68 - 68). LIPPINCOTT WILLIAMS & WILKINS

Bullard, AJ; Govewalla, P; Yellon, DM; (2004) Erythropoetin protects the myocardium from reperfusion injury. In: CIRCULATION. (pp. 301 - 301). LIPPINCOTT WILLIAMS & WILKINS

C

Clapp, LH; (2004) KATP channels, potassium channel openers and smooth muscle. In: (pp. p. 16).

Crestanello, JA; McGregor, CGA; Danielson, GK; Daly, RC; Dearani, JA; Orszulak, TA; Mullany, CJ; ... Schaff, HV; + view all (2004) Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg , 78 (3) pp. 826-831. 10.1016/j.athoracsur.2004.04.008.

D

Davidson, SM; Hausenloy, D; Duchen, MR; Yellon, DM; (2004) Insulin inhibits opening of the mitochondrial permeability transition pore via the reperfusion injury salvage kinase (RISK) pathway. In: CIRCULATION. (pp. 29 - 29). LIPPINCOTT WILLIAMS & WILKINS

Deloukas, P; Earthrowl, ME; Grafham, DV; Rubenfield, M; French, L; Steward, CA; Sims, SK; ... Rogers, J; + view all (2004) The DNA sequence and comparative analysis of human chromosome 10. NATURE , 429 (6990) 375 - 381. 10.1038/nature02462.

Dispenzieri, A; Gertz, MA; Kyle, RA; Lacy, MQ; Burritt, MF; Therneau, TM; Greipp, PR; ... Jaffe, AS; + view all (2004) Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol , 22 (18) pp. 3751-3757. 10.1200/JCO.2004.03.029.

Dispenzieri, A; Gertz, MA; Kyle, RA; Lacy, MQ; Burritt, MF; Therneau, TM; McConnell, JP; ... Jaffe, AS; + view all (2004) Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood , 104 (6) pp. 1881-1887. 10.1182/blood-2004-01-0390.

E

Ebrahim, Z; Baxter, GF; Yellon, DM; (2004) Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism. CARDIOVASC DRUG THER , 18 (2) 127 - 134.

Efthymiou, CA; Mocanu, MM; Mensah, K; Yellon, DM; (2004) Atorvastatin at reperfusion attenuates myocardial infarction by the induction of heat shock protein 27 and p38 MAPK in the isolated perfused mouse heart. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 248 - 249). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Efthymiou, CA; Mocanu, MM; Mensah, K; Yellon, DM; (2004) Reperfusion induced injury attenuated by atorvastatin in an experimental model of myocardial ischaemia/reperfusion: a role for p44/42 mapkinase and PI3kinase. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 249 - 249). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Efthymiou, CA; Mocanu, MM; de Belleroche, J; Wells, DJ; Latchmann, DS; Yellon, DM; (2004) Heat shock protein 27 protects the heart against myocardial infarction. BASIC RES CARDIOL , 99 (6) 392 - 394. 10.1007/s00395-004-0483-6.

Efthymiou, CA; Mocanu, MM; deBelleroche, J; Wells, DM; Latchman, DS; Yellon, DM; (2004) Heat shock protein 27 protects the heart against myocardial infarction. Basic Research in Cardiology , 99 pp. 1-3.

F

Falcetti, E; Tinker, A; Flavell, D; Haworth, SG; Clapp, LH; (2004) Stable transfection of the prostacyclin receptor into HEK-293 cells confers antiproliferative properties to prostacyclin analogues. In: (pp. p. 106). WILEY-BLACKWELL

H

Hausenloy, D; Wynne, A; Duchen, M; Yellon, D; (2004) Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. CIRCULATION , 109 (14) 1714 - 1717. 10.1161/01.CIR.0000126294.81407.7D. Green open access
file

Hausenloy, D; Wynne, A; Yellon, DM; Duchen, M; (2004) Does the mitochondrial permeability transition have a role in preconditioning? Response. CIRCULATION , 110 (11) E303 - E303.

Hausenloy, DJ; Mocanu, MA; Yellon, DM; (2004) Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. CARDIOVASC RES , 63 (2) 305 - 312. 10.1016/j.cardiores.2004.04.011.

Hausenloy, DJ; Wynne, A; Duchen, M; Yellon, DM; (2004) Does the mitochondrial permeability transition pore have a role in preconditioning?-letter to editor. UNSPECIFIED

Hausenloy, DJ; Yellon, DM; (2004) Adenosine-induced second window of protection is mediated by inhibition of mitochondrial permeability transition pore opening at the time of reperfusion. CARDIOVASC DRUG THER , 18 (1) 79 - 80.

Hausenloy, DJ; Yellon, DM; (2004) New directions for protecting the heart against ischaemia-reperfusion injury: Targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovascular Research , 61 (3) pp. 448-460. 10.1016/j.cardiores.2003.09.024.

Hausenloy, DJ; Yellon, DM; (2004) New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. CARDIOVASC RES , 61 (3) 448 - 460. 10.1016/j.cardiores.2003.09.024.

Hausenloy, DJ; Yellon, DM; (2004) The importance of the reperfusion phase in ischaemic preconditioning. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 365 - 365). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Hausenloy, DJ; Yellon, DM; (2004) The mitochondrial permeability transition pore in myocardial preconditioning. Cardiovascular Journal of South Africa , 15 (4) S5-.

Hausenloy, DJ; Yellon, DM; Mani-Babu, S; Duchen, MR; (2004) Preconditioning protects by inhibiting the mitochondrial permeability transition. AM J PHYSIOL-HEART C , 287 (2) H841 - H849. 10.1152/ajpheart.00678.2003.

Hausenloy, DJ; Yellon, DM; Mani-Babu, S; Duchen, MR; (2004) Preconditioning protects by inhibiting the mitochondrial permeability transition. American Journal of Physiology - Heart and Circulatory Physiology , 287 (2 56-2) 10.1152/ajpheart.00678.2003.

Horton, R; Wilming, L; Rand, V; Lovering, RC; Bruford, EA; Khodiyar, VK; Lush, MJ; ... Beck, S; + view all (2004) Gene map of the extended human MHC. NAT REV GENET , 5 (12) 889 - 899. 10.1038/nrg1489.

Hudson, CD; Podesta, J; Henderson, D; Latchman, DS; Budhram-Mahadeo, V; (2004) Coexpression of Brn-3a POU protein with p53 in a population of neuronal progenitor cells is associated with differentiation and protection against apoptosis. J NEUROSCI RES , 78 (6) 803 - 814. 10.1002/jnr.20299.

I

Irshad, S; Pedley, RB; Anderson, J; Latchman, DS; Budhram-Mahadeo, V; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J BIOL CHEM , 279 (20) 21617 - 21627. 10.1074/jbc.M312506200. Gold open access

J

Jabr, RI; Perrino, BA; Clapp, LH; (2004) Nuclear translocation of calcineurin AP isoform in response to platelet-derived growth factor in cultured rat aortic smooth muscle cells. In: BIOPHYSICAL JOURNAL. (pp. 104A - 104A). BIOPHYSICAL SOCIETY

Jin, JP; Cardozo, T; Lovering, RC; Elledge, SJ; Pagano, M; Harper, JW; (2004) Systematic analysis and nomenclature of mammalian F-box proteins. GENE DEV , 18 (21) 2573 - 2580. 10.1101/gad.1255304.

K

Khodiyar, V; Lovering, R; Bruford, E; Talbot, C; Wright, M; Lush, M; Corey, R; ... Wain, H; + view all (2004) Virtual gene nomenclature: making the most of the genomic sequence. In: GENETICAL RESEARCH. (pp. 126 - 127). CAMBRIDGE UNIV PRESS

L

Lawrence, KM; Townsend, P; Davidson, SM; Carroll, CJ; Eaton, S; Hubank, M; Knight, RA; ... Latchman, DS; + view all (2004) The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage. BIOCHEM BIOPH RES CO , 321 (2) 479 - 486. 10.1016/j.bbrc.2004.06.170.

M

Maddock, HL; Siedlecka, SM; Yellon, DM; (2004) Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide. CARDIOVASC DRUG THER , 18 (2) 113 - 119.

McGregor, CGA; Teotia, SS; Byrne, GW; Michaels, MG; Risdahl, JM; Schirmer, JM; Tazelaar, HD; ... Logan, JS; + view all (2004) Cardiac xenotransplantation: progress toward the clinic. Transplantation , 78 (11) pp. 1569-1575. 10.1097/01.tp.0000147302.64947.43.

Mensah, K; Bose, A; Mocanu, M; Yellon, DM; (2004) Short-term pre-treatment with atorvastatin reduces infarct size in an isolated rat heart model of ischaemia/reperfusion injury. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 295 - 295). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Mensah, K; Efthymiou, CA; Mocanu, M; Yellon, DM; (2004) Acute treatment with statins not chronic treatment attenuates infarct in an isolated rat heart model. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 294 - 295). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Mensah, K; Efthymiou, CA; Mocanu, M; Yellon, DM; (2004) Atorvastatin reduces infarct size acutely in an isolated rat heart model. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 295 - 295). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Muqit, MMK; Davidson, SM; Payne-Smith, MD; MacCormac, LP; Wood, NW; Latchman, DS; (2004) Parkin is recruited into aggresomes in a stress-specific manner and its overexpression reduces aggresome formation. In: (Proceedings) Autumn Meeting of the Association-of-British-Neurologists. (pp. p. 517). B M J PUBLISHING GROUP

Muqit, MMK; Davidson, SM; Smith, MDP; MacCormac, LP; Kahns, S; Jensen, PH; Wood, NW; (2004) Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. HUM MOL GENET , 13 (1) 117 - 135. 10.1093/hmg/ddh012.

O

Opie, LH; Jonnesen, A; Yellon, DM; (2004) The glucose hypothesis: Updated or outdated? Role of insulin. Cardiovascular Journal of South Africa , 15 (4) S1-.

P

Potter, DD; Sundt, TM; Zehr, KJ; Dearani, JA; Daly, RC; Mullany, CJ; McGregor, CGA; ... Orszulak, TA; + view all (2004) Risk of repeat mitral valve replacement for failed mitral valve prostheses. Ann Thorac Surg , 78 (1) pp. 67-72. 10.1016/j.athoracsur.2004.02.014.

S

Samady, L; Dennis, J; Budhram-Mahadeo, V; Latchman, DS; (2004) Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor. CANCER BIOL THER , 3 (3) 317 - 323.

Schirmer, JM; Fass, DN; Byrne, GW; Tazelaar, HD; Logan, JS; McGregor, CGA; (2004) Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival. Xenotransplantation , 11 (5) pp. 436-443. 10.1111/j.1399-3089.2004.00159.x.

Shanmuganathan, S; Hausenloy, DJ; Duchen, MR; Yellon, DM; (2004) Inhibiting mitochondrial permeability transition pore opening protects the human myocardium from ischemia-reperfusion injury. In: CIRCULATION. (pp. 235 - 235). LIPPINCOTT WILLIAMS & WILKINS

T

Tinker, A; Clapp, L; Segal, A; (2004) An essential role for BKCa channels in innate immunity. In: BIOPHYSICAL JOURNAL. (pp. 122A - 122A). BIOPHYSICAL SOCIETY

Townsend, PA; Scarabelli, TM; Davidson, SM; Knight, RA; Latchman, DS; Stephanou, A; (2004) STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J BIOL CHEM , 279 (7) 5811 - 5820. 10.1074/jbc.M302637200. Gold open access

Tsang, A; Hausenloy, DJ; Mocanu, MM; Yellon, DM; (2004) Postconditioning - A form of "modified reperfusion" protects the myocardium by activating the PI3K-Akt pathway. In: CIRCULATION. (pp. 167 - 168). LIPPINCOTT WILLIAMS & WILKINS

Tsang, A; Hausenloy, DJ; Mocanu, MM; Yellon, DM; (2004) Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. CIRC RES , 95 (3) 230 - 232. 10.1161/01.RES.0000138303.76488.fe.

V

Veitenhansl, M; Stegner, K; Hierl, F-X; Dieterle, C; Feldmeier, H; Gutt, B; Landgraf, R; ... Sekihara, H; + view all (2004) 40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004. Diabetologia , 47 (Suppl 1) A1-A464. 10.1007/BF03375463.

W

West, TG; Curtin, NA; Ferenczi, MA; He, Z-H; Sun, Y-B; Irving, M; Woledge, RC; (2004) Actomyosin energy turnover declines while force remains constant during isometric muscle contraction. J Physiol , 555 (Pt 1) pp. 27-43. 10.1113/jphysiol.2003.040089.

Y

Yellon, DM; (2004) Reperfusion Injury: The importance of prosurvival signalling. Cardiovascular Journal of South Africa , 15 (4) S4-.

Yellon, DM; (2004) Reperfusion injury: the importance of prosurvival signalling. In: JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. (pp. 771 - 771). ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD

Yin, D; Zeng, H; Ma, L; Shen, J; Xu, H; Byrne, GW; Chong, AS; (2004) Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol , 172 (12) pp. 7235-7238. 10.4049/jimmunol.172.12.7235.

This list was generated on Sun Aug 18 04:13:38 2019 BST.